NOVARTIS AG-REG (NOT.DE) Earnings History & Surprises

FRA:NOTCH0012005267

Current stock price

131.62 EUR
+3.74 (+2.92%)
Last:

NOT.DE Earnings overview

Past quarterly earnings results for NOVARTIS AG-REG (NOT.DE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Apr 27, 2026
Period
Q1 / 2026
EPS Estimate
$2.15
Revenue Estimate
13.825B

Last Reported

Most Recent
Release Date
Feb 4, 2026
Period
Q4 / 2025
EPS Reported
$2.03
EPS Surprise
-0.17%
Revenue Surprise
-4.89%

Beat Rate

Last 8 Quarters
63%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2025 2.03 2.03 -0.17% 2.53% 13.336B 14.022B -4.89% 1.39%
Q3 2025 2.25 2.30 -2.10% 9.22% 13.909B 14.312B -2.82% 5.60%
Q2 2025 2.42 2.41 0.61% 22.84% 14.054B 14.465B -2.84% 9.18%
Q1 2025 2.28 2.14 6.59% 26.67% 13.233B 13.384B -1.13% 9.18%
Q4 2024 1.98 1.87 6.06% 29.41% 13.153B 13.051B 0.78% 11.69%
Q3 2024 2.06 1.99 3.78% 12.57% 13.172B 12.994B 1.37% 8.93%
Q2 2024 1.97 1.91 3.24% 7.65% 12.872B 12.61B 2.08% 9.60%
Q1 2024 1.80 1.71 5.40% 5.26% 12.12B 11.709B 3.51% 9.71%
Q4 2023 1.53 1.65 -7.44% 0.66% 11.776B 11.996B -1.83% 8.24%
Q3 2023 1.83 1.76 3.88% 15.82% 12.092B 12.001B 0.76% 12.14%
Q2 2023 1.83 1.73 5.73% 17.31% 11.745B 13.518B -13.12% -45.91%
Q1 2023 1.71 1.56 9.32% 17.12% 11.047B 12.877B -14.21% -14.64%
Q4 2022 1.52 1.43 6.28% 8.57% 10.88B 13.285B -18.10% 135.55%
Q3 2022 1.58 1.58 -0.02% -7.60% 10.783B 13.106B -17.72% -19.33%
Q2 2022 1.56 1.53 2.08% -6.02% 21.712B 13.109B 65.63% 63.32%
Q1 2022 1.46 1.47 -0.62% -3.95% 12.942B - 1.95%
Q4 2021 1.40 1.45 -3.12% 4.48% 4.619B 13.616B -66.08% -64.55%
Q3 2021 1.71 1.68 1.93% 12.50% 13.367B 13.285B 0.62% 6.61%
Q2 2021 1.66 1.57 5.67% 22.06% 13.294B 12.773B 4.08% 14.39%
Q1 2021 1.52 1.59 -4.32% -2.56% 12.694B 12.771B -0.60% -0.11%
Q4 2020 1.34 1.40 -4.21% - 13.03B 13.147B -0.89% -
Q3 2020 1.52 1.48 2.60% - 12.538B 12.818B -2.18% -
Q2 2020 1.36 1.35 0.78% - 11.622B 12.13B -4.19% -
Q1 2020 1.56 1.42 9.89% - 12.708B 12.249B 3.75% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

NOT.DE EPS Q2Q GrowthNOT.DE EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 0 10 20

Revenue Historical Q2Q growth and Acceleration

NOT.DE Revenue Q2Q GrowthNOT.DE Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 0 50 -50 100

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
2
Average EPS beat (4)
1.23%
Max EPS beat (4)
6.59%
Min EPS beat (4)
-2.10%

Revenue beat statistics

Revenue beat (4)
0
Average Revenue beat (4)
-2.92%
Max Revenue beat (4)
-1.13%
Min Revenue beat (4)
-4.89%

Analysis

In the last 4 quarters, NOT.DE has beaten EPS estimates in 2 out of 4 releases
NOT.DE has not beaten revenue estimates in any of the last 4 earnings releases
In the last 4 quarters, NOT.DE has beaten the EPS estimates by 1.2% on average.
In the last 4 quarters, NOT.DE reported -2.9% below the revenue estimates on average.

NOVARTIS AG-REG / NOT.DE Earnings FAQ

Can you provide the last earnings date for NOVARTIS AG-REG?

NOVARTIS AG-REG (NOT.DE) last reported earnings on 2/4/2026.

Did NOVARTIS AG-REG (NOT.DE) beat earnings estimates last quarter?

NOVARTIS AG-REG (NOT.DE) missed EPS estimates and missed revenue estimates in the most recent quarter.

What percentage of the time does NOT stock beat earnings estimates?

In the last 4 quarters, NOVARTIS AG-REG (NOT.DE) has beaten EPS estimates in 2 out of 4 releases.